Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...
Eli Lilly LLY reported 54% revenue growth in the third quarter as its diabetes and obesity drug tirzepatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback